It is not a cure-all, but it offers a powerful nonsurgical option for many patients
Preclinical and clinical studies demonstrate that co-administration of these peptides achieves superior reductions in bodyweight, appetite, and fasting glucose than either agent aloneachieving up to a 17% reduction in bodyweight in non-diabetic individuals and a 15.6% reduction in patients with type 2 diabetes over 2032 weeks
Where acetate BPC-157 loses approximately 98% of its structure within five hours of gastric acid exposure, the arginate form loses only about 5% in the same timeframe
Kraai Doctors of Physical Therapy 5K followersNaperville, IL Kenneth W
First identified in 1973, GHK-Cu has since gained recognition for its powerful role in wound healing, tissue regeneration, and even gene modulation
An extensive paper highlighted BPC-157s potential to accelerate musculoskeletal soft tissue healing